Back to search

Article

Recent Progress in NKG2D CAR-NK Cells for Cancer Immunotherapy

2026-06-10

Abstract excerpt

Adoptive cellular therapy has emerged as one of the most pivotal modalities in cancer immunotherapy. Although chimeric antigen receptor (CAR)-T cell therapy has achieved remarkable clinical success in hematological malignancies, its broad application is hampered by severe immune-related toxicities, autologous manufacturing limitations, and suboptimal efficacy against most solid tumors, highlighting an urgent unmet...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
48d0bd41-43dd-5484-92e0-53ea0df98027
DOI
10.20944/preprints202606.0883.v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Recent Progress in NKG2D CAR-NK Cells for Cancer ImmunotherapyDOI 10.20944/preprints202606.0883.v1
Leveraging NKG2D Ligands in Immuno-OncologySemantic proximity
Manufacturing development and clinical production of NKG2D chimeric antigen receptor-expressing T cells for autologous adoptive cell therapy.Semantic proximity
Solid tumor immunotherapy using NKG2D-based adaptor CAR T cellsSemantic proximity
Engineering NKG2D ligand affinity transforms EGFR-targeted NK cell engagers into high-potency effectors against pancreatic cancerSemantic proximity
NKG2D Ligands–Critical Targets for Cancer Immune Escape and TherapySemantic proximity
A structural, genetic and clinical comparison of CAR-T cells and CAR-NK cells: companions or competitors?Semantic proximity
In-depth analysis of the interplay between oncogenic mutations and NK cell-mediated cancer surveillance in solid tumors.Semantic proximity
The Role and Regulation of the NKG2D/NKG2D Ligand System in CancerSemantic proximity
Chimeric NKG2D CAR-expressing T cell-mediated attack of human ovarian cancer is enhanced by histone deacetylase inhibition.Semantic proximity
Immunobiology and Conflicting Roles of the Human NKG2D Lymphocyte Receptor and Its Ligands in CancerSemantic proximity
CAR-NK cells for gastrointestinal cancer immunotherapy: from bench to bedsideSemantic proximity
Gene-edited and CAR-NK cells: Opportunities and challenges with engineering of NK cells for immunotherapySemantic proximity
Select a neighboring publication to make it the new centre.